Akt is a protooncogene, and when the genomic data from patient samples of 32 different cancer cell types were analyzed, AKT1 was found to be mutated in 1% and amplified in 3% of 11,219 analyzed cases [40]. This evidence concerns the gene AKT1 and cancer.